Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $25,169,000 | $22,894,000 | $367,950 | $246,557 |
| Short-Term Investments | $23,485,000 | $23,039,000 | $23,706,000 | $23,139,000 |
| Receivables | $29,653,000 | $28,679,000 | $22,779,000 | $22,806,000 |
| Inventory | $24,979,000 | $26,296,000 | $22,798,000 | $18,987,000 |
| Other Curr. Assets | $3,694,000 | $3,643,000 | $5,465,000 | $4,397,000 |
| Total Curr. Assets | $106,980,000 | $104,551,000 | $100,641,000 | $99,342,000 |
| Property Plant & Equip (Net) | $27,069,000 | $24,861,000 | $185,006 | $197,768 |
| Goodwill | $242,000 | $309,000 | $0 | $0 |
| Intangibles | $1,652,000 | $1,683,000 | $1,507,000 | $1,569,000 |
| Long-Term Investments | $107,544,000 | $128,910,000 | $562,824 | $793,848 |
| Tax Assets | $566,000 | $0 | $3,259 | $4,305 |
| Other NC Assets | $2,000 | $610,000 | -$1,350,642 | -$1,425,131 |
| Total NC Assets | $137,075,000 | $156,373,000 | $907,448 | $1,139,790 |
| Other Assets | $4,000 | $5,000 | $0 | $0 |
| Total Assets | $244,059,000 | $260,929,000 | $1,664,972 | $1,955,885 |
| Liabilities | – | – | – | – |
| Payables | $4,602,000 | $4,893,000 | $4,617,000 | $4,104,000 |
| Short-Term Debt | $1,280,000 | $1,340,000 | $1,490,000 | $1,640,000 |
| Tax Payable | $1,474,000 | $2,380,000 | $3,071 | $28,728 |
| Deferred Revenue | $0 | $0 | $13,895 | $22,148 |
| Other Curr. Liab. | $9,222,000 | $9,050,000 | $8,833,034 | $12,949,125 |
| Total Curr. Liab. | $16,578,000 | $17,663,000 | $14,957,000 | $18,744,000 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $16,481,000 | $21,188,000 | $78,477 | $133,568 |
| Other NC Liab. | $875,000 | $940,000 | $7,527 | $9,907 |
| Total NC Liab. | $17,356,000 | $22,128,000 | $86,004 | $143,475 |
| Other Liabilities | $0 | $4,000 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $33,934,000 | $39,795,000 | $198,585 | $297,457 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $24,356,000 | $24,356,000 | $24,356,000 | $24,356,000 |
| Retained Earnings | $131,488,000 | $127,310,000 | $125,576,000 | $118,183,000 |
| AOCI | $0 | $0 | $32,653,000 | $47,532,000 |
| Other Equity | $53,159,000 | $68,363,000 | $11,314,000 | $11,314,000 |
| Total Equity | $209,003,000 | $220,029,000 | $193,899,000 | $201,384,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $1,122,000 | $1,107,000 | $6,880 | $6,523 |
| Total Liab. & Tot. Equity | $244,059,000 | $260,929,000 | $1,664,950 | $1,958,366 |
| Net Debt | -$23,889,000 | -$21,554,000 | $1,122,050 | $1,393,443 |